Kura Oncology, Inc. (KURA) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow (NASDAQ:KURA) 2026-06-13
Kura Oncology, Inc. (KURA) Discusses Long-Term Results of Ziftomenib Combination Therapies in Newly Diagnosed and Relapsed/Refractory AML Transcript
Kura Oncology, Inc. (KURA) Discusses Clinical Data and Updated Development Strategy for Darlifarnib - Slideshow (NASDAQ:KURA) 2026-06-05
Kura Oncology, Inc. (KURA) Discusses Clinical Data and Updated Development Strategy for Darlifarnib Transcript
Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma - Slideshow (NASDAQ:KURA) 2026-04-21